Fresubin nutrition products: how Fresenius Kabi supports recovery

Fresubin medical nutrition products from Fresenius Kabi are designed to support people at risk of disease-related malnutrition, complementing medical care in hospitals, nursing homes, and at home.

Fresubin medical nutrition products from Fresenius Kabi are designed for patients who struggle to meet their nutritional needs due to illness, injury, or surgery, according to the companys medical nutrition materialsFresenius Kabi, 03/2025.

Updated: 05/19/2026 | Reading time: approx. 8 minutes

By the AD HOC NEWS editorial team - specialized in product-led market coverage.

At a Glance

• Product: Fresubin medical nutrition range
• Category: Oral and enteral medical nutrition
• Brand/Manufacturer: Fresenius Kabi
• Main Use Cases: Nutritional support in disease-related malnutrition

What Fresubin medical nutrition is and how it works

Fresubin is a family of medical nutrition products developed by Fresenius Kabi to help manage or prevent disease-related malnutrition in adults and children who cannot cover their needs with normal food aloneFresenius Kabi, 03/2025.

The range includes energy-dense and protein-rich oral nutritional supplements like ready-to-drink shakes and puddings, as well as tube feeding formulas for patients who require enteral nutrition via feeding tubesFresenius Kabi, 03/2025.

Fresubin formulas are typically enriched with macronutrients and selected vitamins and minerals, and many variants are designed to be lactose-free and gluten-free to support tolerance in sensitive patientsFresenius Kabi, 03/2025.

Why Fresubin medical nutrition matters for patients and providers

Disease-related malnutrition is common among hospitalized and chronically ill patients and is associated with poorer clinical outcomes and higher health care costs, according to the American Society for Parenteral and Enteral NutritionASPEN, 04/2024.

Oral nutritional supplements like Fresubin can be used as part of nutrition therapy when standard meals are not sufficient, helping to support energy and protein intake as recommended by clinical nutrition guidelinesASPEN, 04/2024.

For hospitals and long term care facilities, having standardized medical nutrition options can make it easier to implement nutrition protocols in line with evidence-based recommendations from groups such as ASPEN and the European Society for Clinical Nutrition and MetabolismESPEN, 09/2023.

Fresubin medical nutrition in the US and global market

Fresenius Kabi states that it is a global health care company with a focus on clinical nutrition, infusion, and transfusion technologies, and it markets medical nutrition products in numerous countries worldwideFresenius Kabi, 02/2025.

In the United States, Fresenius Kabi offers parenteral and enteral nutrition solutions and works with hospitals, outpatient clinics, and home care providers, in line with US regulatory requirements set by the Food and Drug Administration for medical foods and related productsFDA, 05/2023.

Global demand for medical nutrition is supported by aging populations and rising prevalence of chronic disease, trends highlighted in clinical nutrition market analysis by major health care industry research firmsBloomberg, 08/2024.

• Oral nutritional supplements: ready-to-drink liquids and desserts for patients who can swallow but need extra nutrients.
• Enteral tube feeds: formulas given via feeding tubes when oral intake is not possible or not sufficient.
• Specialized formulas: tailored options for conditions that require adjusted macronutrient compositions.
• Multi-flavor offerings: taste variety to support adherence in long term use.

Fresubin medical nutrition products are part of the broader Fresenius Kabi clinical nutrition portfolio, which operates under the health care group Fresenius SE & Co. KGaAFresenius, 03/2025.

Fresenius SE & Co. KGaA is listed in Germany with the ordinary share traded under the ticker FRE and the ISIN DE0005785604Fresenius, 04/2025.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.